BNET Industries
Market Cap:$59.0M
Last Fiscal Year Sales:$1.4M
- Public
- US
Dow Jones Description
PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA). PURE's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today's global trend toward industry and consumer use of "green" products while providing competitive advantages in efficacy and safety. Patented SDC is an electrolytically generated source of stabilized ionic silver which formulates well with other compounds. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area).
Number of Employees 15
Peer Companies
NAICS Code Pesticide and Other Agricultural Chemical Manufacturing: 325320
Recent Events
-
Swish and Enviro-Solutions to Launch SDC-Based Disinfectants in Canada and US
-
PURE Bioscience signs agreement with Richmont Sciences
-
BRIEF-Pure Bioscience reports full year results
-
PURE Bioscience Reports Third Quarter and Nine-Month Results
News & Analysis
Filter by
pure bioscience and sales - All News and Analysis
PURE Bioscience Announces Launch of Earth Friendly Chemicals' QuikCharge® SDC
New "Powered by SDC[TM]" Disinfectant Launched at Pumper & Cleaner Environmental Expo SAN DIEGO -- PURE Bioscience (OTCBB: PURE) today announced the launch of QuikCharge[R] SDC by Earth Friendly Chemicals. The latest private label brand of PURE's patented silver dihydrogen citrate SDC-based disinfectant was introduced at the 2008 Pumper...
PURE Bioscience Completes Sale of Water Treatment Division — Debt-Free, PURE Accelerates Sales and Development of Bioscience Products; Schedules Conference Call to Discuss Ongoing Bioscience Business Outlook
SAN DIEGO -- PURE Bioscience (OTCBB:PURE) today announced it has completed the sale of its water treatment division to Maryland-based Innovative Medical Services, LLC for $2.375 million. At closing, PURE received $1.95M in cash. The Company will also receive two post-closing payments -- one in the amount of $225,000...
PURE Bioscience Announces Development and Distribution Agreement with Ciba Specialty Chemicals
SAN DIEGO -- Ciba Specialty Chemicals to Market and Sell PURE's Silver Dihydrogen Citrate Antimicrobial into Personal Care and Household Care Markets PURE Bioscience (OTCBB:PURE) today announced it has signed an agreement licensing Ciba Specialty Chemicals (SWX:CIBN) (NYSE:CSB) to market and sell PURE's silver dihydrogen citrate antimicrobial. The...
PURE Bioscience Receives Key Product Registration from State of California; Long-Awaited Milestone Opens Doors for Nation-Wide Marketing and Sales of Powerful Disinfectant
SAN DIEGO -- PURE Bioscience (OTCBB:PURE) today announced that its silver dihydrogen citrate-based hard surface disinfectant has been registered by the California Department of Pesticide Regulation. Axen30 hard surface disinfectant is also registered by the U.S. Environmental Protection Agency EPA and each of the 49 other states. Michael L....
- 1
Industry Transcripts by Seeking Alpha
-
Deere & Company F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Nov 25, 2009about DE
-
Brown Shoe Co. Inc. Q3 2009 Earnings Call Transcript
on Nov 24, 2009about BWS
-
Daktronics Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 24, 2009about DAKT
-
Haynes International Inc. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Nov 24, 2009about HAYN
-
Valspar Corp. F4Q09 (Qtr End 30/10/09) Earnings Call Transcript
on Nov 23, 2009about VAL



